Yet, our data already demonstrate that in individuals with type 2 diabetes or insulin resistance, a high plasma MNA level indicates a high level of tissue NNMT expression and that MNA could be used to identify patients eligible for therapy with an NNMT inhibitor and to monitor their treatment response. This evidence concerns the gene NNMT and type 2 diabetes mellitus.